274 related articles for article (PubMed ID: 17646164)
1. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits protein isoprenylation in the brain.
Ostrowski SM; Johnson K; Siefert M; Shank S; Sironi L; Wolozin B; Landreth GE; Ziady AG
Neuroscience; 2016 Aug; 329():264-74. PubMed ID: 27180285
[TBL] [Abstract][Full Text] [Related]
3. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses.
Cordle A; Landreth G
J Neurosci; 2005 Jan; 25(2):299-307. PubMed ID: 15647473
[TBL] [Abstract][Full Text] [Related]
4. Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism.
Cole SL; Grudzien A; Manhart IO; Kelly BL; Oakley H; Vassar R
J Biol Chem; 2005 May; 280(19):18755-70. PubMed ID: 15718241
[TBL] [Abstract][Full Text] [Related]
5. Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms.
Parsons RB; Price GC; Farrant JK; Subramaniam D; Adeagbo-Sheikh J; Austen BM
Biochem J; 2006 Oct; 399(2):205-14. PubMed ID: 16803455
[TBL] [Abstract][Full Text] [Related]
6. Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons.
Hosaka A; Araki W; Oda A; Tomidokoro Y; Tamaoka A
Neurochem Res; 2013 Mar; 38(3):589-600. PubMed ID: 23269484
[TBL] [Abstract][Full Text] [Related]
7. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
8. Statin-specific inhibition of Rab-GTPase regulates cPKC-mediated IKs internalization.
Ronzier E; Parks XX; Qudsi H; Lopes CM
Sci Rep; 2019 Nov; 9(1):17747. PubMed ID: 31780674
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of statin-mediated inhibition of small G-protein function.
Cordle A; Koenigsknecht-Talboo J; Wilkinson B; Limpert A; Landreth G
J Biol Chem; 2005 Oct; 280(40):34202-9. PubMed ID: 16085653
[TBL] [Abstract][Full Text] [Related]
10. Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.
Shinohara M; Sato N; Kurinami H; Takeuchi D; Takeda S; Shimamura M; Yamashita T; Uchiyama Y; Rakugi H; Morishita R
J Biol Chem; 2010 Jul; 285(29):22091-102. PubMed ID: 20472556
[TBL] [Abstract][Full Text] [Related]
11. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
12. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases.
Ghittoni R; Patrussi L; Pirozzi K; Pellegrini M; Lazzerini PE; Capecchi PL; Pasini FL; Baldari CT
FASEB J; 2005 Apr; 19(6):605-7. PubMed ID: 15677697
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin enhances ecto-5'-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases.
Ledoux S; Laouari D; Essig M; Runembert I; Trugnan G; Michel JB; Friedlander G
Circ Res; 2002 Mar; 90(4):420-7. PubMed ID: 11884371
[TBL] [Abstract][Full Text] [Related]
15. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
16. Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
McCarty MF
Med Hypotheses; 2002 Sep; 59(3):268-79. PubMed ID: 12208152
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.
Hausding M; Witteck A; Rodriguez-Pascual F; von Eichel-Streiber C; Förstermann U; Kleinert H
Br J Pharmacol; 2000 Oct; 131(3):553-61. PubMed ID: 11015307
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
[TBL] [Abstract][Full Text] [Related]
20. The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase.
Schmidmaier R; Baumann P; Simsek M; Dayyani F; Emmerich B; Meinhardt G
Blood; 2004 Sep; 104(6):1825-32. PubMed ID: 15161667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
